Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is developing new therapeutics to address the problem of vascular dysfunction to address the unmet needs of patients in three important indications: Acute Respiratory Disease Syndrome (ARDS), glaucoma, and chronic kidney disease. Mannin is raising Series A/Mezzanine capital of up to $40 million to advance its clinical programs in ARDS, glaucoma and chronic kidney disease.

Mannin Research logo



Event details

Date: January 9 - 11, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


13 in total